Modified release Pharmaceutical composition comprising areas of immediate release and areas of delayed release of acid, 2 - [3 - cyano - 4 - (2-methylpropoxy) phenyl] - 4 - 5 - metiltiazol carboxilicOr (febuxostat), a selective inhibitor of xanthine oxidoreductase； dosage form； and a method of treatment for gout, among others.

• 收藏
• 分享

专利权人:

TAKEDA PHARMACEUTICALS NORTH AMERICA INC.

发明人:

TANEJA RAJNEESH,GUPTE VIJAY,VAKILYNEJAD MAJID

申请号：

CL2012003548

公开号：

CL2012003548A1

申请日:

2012.12.14

申请国别(地区):

CL

年份:

2013

代理人:

摘要：

The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.COMPOSICION FARMACEUTICA ORAL DE LIBERACION MODIFICADA, QUE COMPRENDE UNA MEZCLA DE ESFERAS DE LIBERACION INMEDIATA DE FEBUXOSTAT, CON ESFERAS DE LIBERACION DEMORADA, ESFERAS DE LIBERACION DEMORADA-CONTROLADA O ESFERAS DE LIBERACION CONTROLADA DE FEBUXOSTAT； Y USO PARA EL TRATAMIENTO DE GOTA, HIPERURICEMIA, ENTRE OTROS.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/